FDA Inspection 1193365 - Piedmont Reproductive Endocrinology Group, Pa - December 06, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Piedmont Reproductive Endocrinology Group, Pa, with an inspection on December 6, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Piedmont Reproductive Endocrinology Group, Pa
Inspection Date: December 6, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 69e41309-dade-4b59-8c03-0ac021f37409